Total buying$00 buys
MAZE
Maze Therapeutics, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$1.56M4 sells
Net open-market−$1.56MBuying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 02, 2026
Open-market transaction mix · 4 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 1 | 0 | $0 | $202k | -$202k |
| Oct 2026 | 0 | 3 | 0 | $0 | $1.36M | -$1.36M |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (2)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- CV-$932.3k
- BH-$266.6k
- DA-$124.8k
MAZE transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
MAZEMaze Therapeutics, Inc. | Coloma Jason VCEO | S · sale10b5-1 detectedSEC filing ↗ | -$862kView disclosure → | |
MAZEMaze Therapeutics, Inc. | Coloma Jason VCEO | S · sale10b5-1 detectedSEC filing ↗ | -$70.0kView disclosure → | |
MAZEMaze Therapeutics, Inc. | Bernstein HaroldPRES · R · D · CMO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
MAZEMaze Therapeutics, Inc. | Bernstein HaroldPRES · R · D · CMO | S · sale10b5-1 detectedSEC filing ↗ | -$434kView disclosure → | |
MAZEMaze Therapeutics, Inc. | Bernstein HaroldPRES · R · D · CMO | M · exercise10b5-1 detectedSEC filing ↗ | $168kView disclosure → | |
MAZEMaze Therapeutics, Inc. | Dandekar AtulCSBO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
MAZEMaze Therapeutics, Inc. | Dandekar AtulCSBO | S · sale10b5-1 detectedSEC filing ↗ | -$202kView disclosure → | |
MAZEMaze Therapeutics, Inc. | Dandekar AtulCSBO | M · exercise10b5-1 detectedSEC filing ↗ | $78.1kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period8transactionstxns
- M · Option exercise · dominant4 · 50%
- S · Open-market sells4 · 50%
Activity by reported role
A joint filing can contribute to multiple rolesCMO3
CSBO3
D3
PRES3
R3
Chief executive officer2
Reported Holdings After
Separated by insider, security, and ownership type
Dandekar AtulCommon Stock · Direct
32,316Sep 29, 2026
Bernstein HaroldCommon Stock · Direct
0Oct 01, 2026
Dandekar AtulStock Option (Right to Buy) · Direct
6,643Sep 29, 2026
Bernstein HaroldStock Option (Right to Buy) · Direct
144,521Oct 01, 2026
Coloma Jason VCommon Stock · Indirect · The Coloma 2021 Irrevocable Trust
15,558Oct 01, 2026
Coloma Jason VCommon Stock · Indirect · Coloma Family Trust
191,447Oct 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Maze Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Maze Therapeutics, Inc.?
Coloma Jason V, Bernstein Harold, Dandekar Atul.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Coloma Jason V reported a sale on Oct 01, 2026 valued at $862k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,569,923.62. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.